{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(5)"],"submitter":["Garriga-Baraut T"],"funding":["Thermo Fisher Scientific","Alk-Abelló","Allergy-Therapeutics","Roxall","Stallergenes Greer Laboratories","Leti","Diater","Hal-Allergy"],"pubmed_abstract":["<h4>Background</h4>Recognition of specific allergens triggering immune response is key for the appropriate prescription of allergen-specific immunotherapy (SIT). This study aimed at evaluating the impact of using the commercially available microarray ImmunoCAP<sup>TM</sup> ISAC 112 (Thermo Fisher Scientific) on the etiological diagnosis and SIT prescription compared to the conventional diagnostic methods in patients with allergic rhinitis/rhinoconjunctivitis and/or asthma.<h4>Methods</h4>300 patients with respiratory allergic disease, sensitized to three or more pollen aeroallergens from different species, as assessed by a skin prick test (SPT) and specific IgE assays (sIgE), were included in this multicentric, prospective observational study. SPT and a blood test were performed to all pat"],"journal":["Clinical and translational allergy"],"pagination":["e12246"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10154984"],"repository":["biostudies-literature"],"pubmed_title":["INMUNOCAT study: The impact of molecular diagnosis on immunotherapy prescription in pollen polysensitized patients from Catalonia."],"pmcid":["PMC10154984"],"pubmed_authors":["Comitè d’Al·lèrgia Respiratòria de Catalunya, Spain","Bobolea I","Farrarons L","Miquel S","Tena M","Bartra J","Labrador-Horrillo M","Pedemonte C","Garriga-Baraut T","Moncin MMSM","Asensio O","De Linares C","Raga E","Vinas M","Munoz-Cano R","Padro-Casas C","Belmonte J"],"additional_accession":[]},"is_claimable":false,"name":"INMUNOCAT study: The impact of molecular diagnosis on immunotherapy prescription in pollen polysensitized patients from Catalonia.","description":"<h4>Background</h4>Recognition of specific allergens triggering immune response is key for the appropriate prescription of allergen-specific immunotherapy (SIT). This study aimed at evaluating the impact of using the commercially available microarray ImmunoCAP<sup>TM</sup> ISAC 112 (Thermo Fisher Scientific) on the etiological diagnosis and SIT prescription compared to the conventional diagnostic methods in patients with allergic rhinitis/rhinoconjunctivitis and/or asthma.<h4>Methods</h4>300 patients with respiratory allergic disease, sensitized to three or more pollen aeroallergens from different species, as assessed by a skin prick test (SPT) and specific IgE assays (sIgE), were included in this multicentric, prospective observational study. SPT and a blood test were performed to all pat","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-07-05T03:05:05.841Z","creation":"2025-02-19T03:30:33.054Z"},"accession":"S-EPMC10154984","cross_references":{"pubmed":["37227418"],"doi":["10.1002/clt2.12246"]}}